{"id":"diazepam-injectable-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Drowsiness and sedation"},{"rate":null,"effect":"Dizziness and ataxia"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Dependence and withdrawal"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Diazepam is a benzodiazepine that binds allosterically to GABA-A receptors, potentiating the effect of the inhibitory neurotransmitter GABA. This results in increased chloride ion influx into neurons, leading to hyperpolarization and reduced firing. The injectable formulation provides rapid onset for acute management of seizures, muscle spasms, and anxiety.","oneSentence":"Diazepam enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, reducing neuronal excitability.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:32:44.939Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute seizures and status epilepticus"},{"name":"Acute anxiety and agitation"},{"name":"Muscle spasms and spasticity"},{"name":"Alcohol withdrawal syndrome"},{"name":"Preoperative sedation"}]},"trialDetails":[{"nctId":"NCT06935331","phase":"PHASE4","title":"Prospective Opioid-Free AIS Fusion","status":"NOT_YET_RECRUITING","sponsor":"OrthoCarolina Research Institute, Inc.","startDate":"2025-08-15","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":58},{"nctId":"NCT02078336","phase":"PHASE4","title":"Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-12","conditions":"Dental Care for Disabled","enrollment":40},{"nctId":"NCT02340806","phase":"NA","title":"Association Between Bolus Rate and the Adequacy of Labor Analgesia Using Timed-intermittent Boluses","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-01","conditions":"Labor Pain, Obstetric Pain","enrollment":220},{"nctId":"NCT01364558","phase":"PHASE1","title":"A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2011-02","conditions":"Epilepsy","enrollment":24},{"nctId":"NCT03877120","phase":"PHASE4","title":"Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán","status":"COMPLETED","sponsor":"Centro Medico Nacional La Raza, IMSS","startDate":"2017-11-01","conditions":"Alcohol Withdrawal Delirium","enrollment":2},{"nctId":"NCT00319501","phase":"PHASE3","title":"Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-01","conditions":"Seizures, Epilepsies, Partial, Epilepsy, Complex Partial","enrollment":234},{"nctId":"NCT02313337","phase":"PHASE4","title":"The Comparison of Different Administration Routes of Pediatric Premedication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2014-12","conditions":"Anesthesia","enrollment":80},{"nctId":"NCT02232035","phase":"PHASE2","title":"Diazepam at the Active Phase of Labor","status":"UNKNOWN","sponsor":"Navy General Hospital, Beijing","startDate":"2014-09","conditions":"Pain, Prolonged Labour","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Diazepam Injectable Solution","genericName":"Diazepam Injectable Solution","companyName":"Centro Medico Nacional La Raza, IMSS","companyId":"centro-medico-nacional-la-raza-imss","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diazepam enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, reducing neuronal excitability. Used for Acute seizures and status epilepticus, Acute anxiety and agitation, Muscle spasms and spasticity.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}